NSE seeks clarification from Fischer Medical Ventures on Q4 FY26 results

Regulatory & Legal

FISCHER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+5.4%1-day move

₹36.18

prior close

₹35.55

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0-0.5+5.4+15.9+12.9+7.0+9.0+4.8+9.3+5.0——

Up moveDown movePending

AI summary

NSE has asked Fischer Medical Ventures Limited to clarify certain points related to its financial results for the quarter ended 31 March 2026 under SEBI Listing Regulations. The clarification is sought under Regulation 33, which governs the filing of financial results. The company's response is still awaited. This is a routine exchange query and not a penalty or enforcement action at this stage.

Likely market impact

Routine query for now; watch for the company's response. No immediate impact on trading expected unless material issues are flagged later.